title: Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma.
authors: University of Chicago, Chicago, IL, USA University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
authors: Dominik
authors: D
authors: Dytfeld
authors: University of Chicago, Chicago, IL, USA.
authors: Jagoda
authors: J
authors: Jasielec
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Kent A
authors: KA
authors: Griffith
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Daniel
authors: D
authors: Lebovic
authors: The John Theurer Cancer Center at Hackensack UMC, Hackensack, NJ, USA.
authors: David H
authors: DH
authors: Vesole
authors: Mount Sinai Medical Center, New York, NY, USA.
authors: Sundar
authors: S
authors: Jagannath
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Ammar
authors: A
authors: Al-Zoubi
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Tara
authors: T
authors: Anderson
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Kristen
authors: K
authors: Detweiler-Short
authors: Washington University School of Medicine, St. Louis, MO, USA.
authors: Keith
authors: K
authors: Stockerl-Goldstein
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Asra
authors: A
authors: Ahmed
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Terri
authors: T
authors: Jobkar
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Diane E
authors: DE
authors: Durecki
authors: University of Chicago, Chicago, IL, USA.
authors: Kathryn
authors: K
authors: McDonnell
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Melissa
authors: M
authors: Mietzel
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Daniel
authors: D
authors: Couriel
authors: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
authors: Mark
authors: M
authors: Kaminski
authors: Washington University School of Medicine, St. Louis, MO, USA.
authors: Ravi
authors: R
authors: Vij
authors: University of Chicago, Chicago, IL, USA University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA ajakubowiak@medicine.bsd.uchicago.edu.
authors: Andrzej J
authors: AJ
authors: Jakubowiak
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D009842:Oligopeptides / Q000627:therapeutic use*; D016019:Survival Analysis; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D009842:Oligopeptides; D013792:Thalidomide; C524865:carfilzomib; D003907:Dexamethasone; D000077269:Lenalidomide
keywords: carfilzomib; elderly; lenalidomide; low-dose dexamethasone; multiple myeloma; newly diagnosed